Morningstar DBRS Upgrades Big Pharma Preferred Shares and Revises Securitization Ratings

Credit rating agency Morningstar DBRS has upgraded the preferred shares of Big Pharma Split Corp. to a high-grade investment category. Simultaneously, the firm published a revised analytical framework for rating consumer and commercial asset-backed securities across European and Asia-Pacific markets.